Effect of troponin I and coagulation parameters on mortality in COVID-19 patients
dc.authorid | BULUT, NILUFER/0000-0003-2263-1017 | |
dc.authorwosid | BULUT, Nilüfer/HJH-8128-2023 | |
dc.contributor.author | Dag, Meral | |
dc.contributor.author | Bulut, Nilufer | |
dc.contributor.author | Taskapan, M. Cagatay | |
dc.date.accessioned | 2024-08-04T20:54:30Z | |
dc.date.available | 2024-08-04T20:54:30Z | |
dc.date.issued | 2023 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Objective: Our aim is to determine the levels of troponin-I and some coagulation markers (D-dimer, fibrinogen and International Normalized Ratio (INR)) in coronavirus disease 2019 (COVID-19) patients and to investigate the effects of these markers on mortality.Patients and Method: It is planned as a descriptive, cross-sectional and analytical study. The study was conducted by retrospectively scanning the files of COVID-19 patients who applied to Inonu University Turgut Ozal Medical Center between 01.03.2020 and 31.12.2020. Levels of cardiac troponin I markers and coagulation parameters (D-dimer, fibrinogen and INR) were detected.Results: The results of a total of 1858 patients were obtained. One thousand, three hundred and twenty-six patients with only troponin I and D-dimer results (Group 1), 606 patients with only troponin I and fibrinogen results (Group 2), and 1308 patients with only troponin I and INR results (Group 3) were included. Troponin I levels were significantly higher in all patients who died. 96.6% of the patients with high D-dimer levels died in Group 1, 85.5% of the patients with high fibrinogen levels died in Group 2 and 77.3 % of the patients with high INR levels died in Group 3.Conclusion: Measurements of troponin-I and coagulation markers such as D-dimer, fibrinogen and INR can help predict clinical severity and mortality in COVID-19 patients. | en_US |
dc.identifier.doi | 10.5472/marumj.1235703 | |
dc.identifier.endpage | 139 | en_US |
dc.identifier.issn | 1309-9469 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-85164263692 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 133 | en_US |
dc.identifier.uri | https://doi.org/10.5472/marumj.1235703 | |
dc.identifier.uri | https://hdl.handle.net/11616/101455 | |
dc.identifier.volume | 36 | en_US |
dc.identifier.wos | WOS:000926968200020 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Marmara Univ, Fac Medicine | en_US |
dc.relation.ispartof | Marmara Medical Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Troponin I | en_US |
dc.subject | Coagulation markers | en_US |
dc.subject | D-dimer | en_US |
dc.subject | Fibrinogen | en_US |
dc.subject | International Normalized Ratio | en_US |
dc.title | Effect of troponin I and coagulation parameters on mortality in COVID-19 patients | en_US |
dc.type | Article | en_US |